Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accreditation, admission, Amy, ASU, bolstered, CAP, catastrophic, Chinese, CLIA, cloud, commented, concomitant, conventional, CUHK, deeper, denial, depict, devoted, draft, England, evolution, exploitation, fall, false, FGx, ForenSeq, Foster, guide, Hong, Hospital, inspection, inter, John, Kong, LDT, leadership, Leland, Lincoln, LLC, modified, Myraqa, NGS, noninvasive, Northern, novation, occasionally, ofour, paradigm, penetrate, predominantly, predominately, prejudice, principle, prioritize, proficiency, promised, QSR, recall, reconsidering, reexamining, remand, restated, retrospective, sabotage, scanner, Sequenom, Stanford, stipulated, stringent, sublicense, suggesting, surrender, true, undetected, upfront, VeriSeq, Zebala
Removed:
acute, addressed, analyzed, Analyzer, approximated, assembled, assist, automation, bacteria, bad, bead, biologic, breadth, British, broaden, broadly, capture, challenged, chart, chemically, chronic, CKH, cleared, closely, collaborative, Columbia, confidentiality, consultation, content, copyright, deem, delivering, demonstrated, dependable, developer, diagnose, diagnosing, doubt, downturn, ensuring, epigenetic, erode, etched, European, executed, exploring, faster, fewest, fine, focused, fueled, GAIIx, greatly, handle, heart, highest, ideal, IGN, illuminaDx, imaged, imaging, impair, implemented, import, importantly, improvement, initiative, integral, interpret, invalidated, investigating, involuntary, largest, leverage, linked, long, Luminex, makeup, manufactured, mappable, mapping, marketer, metabolism, microscope, migrate, modern, monitor, narrowed, notified, offsetting, open, outplacement, output, partnered, partnership, PCR, perfect, personalized, physician, play, polymerase, pound, presence, preserve, preventative, producer, program, prompted, reaction, read, reassessed, receiving, recessionary, recommended, refund, reject, relevance, repay, repeatable, representative, reproducible, repurchasing, resolved, returned, role, scope, seeking, sequestration, setting, silica, silicon, skilled, slide, solicitation, southern, sparking, standardized, sterling, streamlined, therapy, thereto, trademark, treat, turnaround, unanimously, unapproachable, unmatched, ushering, workflow
Filing tables
Filing exhibits
- 10-K Annual report
- 10.23 First Amendment to Amenden and Restated Lease Agreement
- 10.24 Second Amendment to Amended and Restated Lease Agreement
- 10.26 Lease Between Bmr-lincoln Centre LP and Illumina
- 10.27 Exhibit 10.27 Pooled Patent Agreement
- 21.1 Subsidiaries of Illumina
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 CEO Certification Pursuant to Section 302 of the Sarbanes-oxley Act
- 31.2 CFO Certification Pursuant to Section 302 of the Sarbanes-oxley Act
- 32.1 CEO Certification Pursuant to 18 U.s.c Section 1350
- 32.2 CFO Certification Pursuant to 18 U.s.c Section 1350
- Download Excel data file
- View Excel data file
Related press release
ILMN similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statements (Form S-3 Nos. 333-111496, 333-125100, 333-134012, 333-144953, 333-145408 and 333-168395) of Illumina, Inc.,
(2) Registration Statement (Form S-4 No. 333-139111) of Illumina, Inc., and
(3) Registration Statements (Form S-8 Nos. 333-42866, 333-69058, 333-88808, 333-104190, 333-114633, 333-124074, 333-125133, 333-129611, 333-134399, 333-140416, 333-147389, 333-151625, 333-159662, 333-168393, 333-188037 and 333-190322) of Illumina, Inc.;
of our reports dated February 17, 2015, with respect to the consolidated financial statements and schedule of Illumina, Inc., and the effectiveness of internal control over financial reporting of Illumina, Inc., included in this Annual Report (Form 10-K) for the fiscal year ended December 28, 2014.
/s/ Ernst & Young LLP
San Diego, California
February 17, 2015